Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 3
1958 2
1959 5
1960 2
1961 1
1962 1
1963 2
1964 2
1965 4
1966 1
1967 3
1968 6
1969 4
1970 4
1971 6
1972 6
1973 10
1974 9
1976 3
1977 2
1978 2
1979 6
1980 1
1981 4
1982 3
1983 5
1984 4
1985 5
1986 3
1987 2
1988 4
1989 5
1990 3
1991 6
1992 9
1993 4
1994 10
1995 6
1996 7
1997 12
1998 10
1999 9
2000 8
2001 5
2002 1
2003 8
2004 9
2005 8
2006 7
2007 12
2008 13
2009 20
2010 16
2011 15
2012 13
2013 17
2014 11
2015 24
2016 18
2017 11
2018 13
2019 18
2020 19
2021 15
2022 32
2023 30
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

511 results

Results by year

Filters applied: . Clear all
Page 1
Bell's palsy: diagnosis and management.
Tiemstra JD, Khatkhate N. Tiemstra JD, et al. Am Fam Physician. 2007 Oct 1;76(7):997-1002. Am Fam Physician. 2007. PMID: 17956069 Free article. Review.
Bell's palsy is a peripheral palsy of the facial nerve that results in muscle weakness on one side of the face. Affected patients develop unilateral facial paralysis over one to three days with forehead involvement and no other neurologic abnormalities …
Bell's palsy is a peripheral palsy of the facial nerve that results in muscle weakness on one side of the face. Affected patie …
Clinical practice guideline: Bell's palsy.
Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R, Deckard NA, Dawson C, Driscoll C, Gillespie MB, Gurgel RK, Halperin J, Khalid AN, Kumar KA, Micco A, Munsell D, Rosenbaum S, Vaughan W. Baugh RF, et al. Otolaryngol Head Neck Surg. 2013 Nov;149(3 Suppl):S1-27. doi: 10.1177/0194599813505967. Otolaryngol Head Neck Surg. 2013. PMID: 24189771
OBJECTIVE: Bell's palsy, named after the Scottish anatomist, Sir Charles Bell, is the most common acute mono-neuropathy, or disorder affecting a single nerve, and is the most common diagnosis associated with facial nerve weakness/paralysis. Bell's palsy is a …
OBJECTIVE: Bell's palsy, named after the Scottish anatomist, Sir Charles Bell, is the most common acute mono-neuropathy, or disorder affecti …
Facial Rehabilitation: Evaluation and Treatment Strategies for the Patient with Facial Palsy.
Robinson MW, Baiungo J. Robinson MW, et al. Otolaryngol Clin North Am. 2018 Dec;51(6):1151-1167. doi: 10.1016/j.otc.2018.07.011. Epub 2018 Sep 24. Otolaryngol Clin North Am. 2018. PMID: 30262166 Review.
This article describes the most widely used clinician-graded and patient-reported outcome measures, and describes facial rehabilitation strategies for acute and chronic facial palsy, and rehabilitation following dynamic facial reanimation surgery. ...Appropri …
This article describes the most widely used clinician-graded and patient-reported outcome measures, and describes facial rehabilitati …
Effect of proprioceptive neuromuscular facilitation in the treatment of dysfunctions in facial paralysis: a systematic literature review.
Silva MC, Oliveira MT, Azevedo-Santos IF, DeSantana JM. Silva MC, et al. Braz J Phys Ther. 2022 Nov-Dec;26(6):100454. doi: 10.1016/j.bjpt.2022.100454. Epub 2022 Oct 17. Braz J Phys Ther. 2022. PMID: 36279766 Free PMC article. Review.
Randomized controlled trials of PNF in individuals with dysfunctions caused by facial paralysis were eligible. Outcomes measures were recovery rate and clinical recovery, both measured by using the House Brackmann Scale. ...CONCLUSION: We conclude that given the lim …
Randomized controlled trials of PNF in individuals with dysfunctions caused by facial paralysis were eligible. Outcomes measur …
Management of peripheral facial nerve palsy.
Finsterer J. Finsterer J. Eur Arch Otorhinolaryngol. 2008 Jul;265(7):743-52. doi: 10.1007/s00405-008-0646-4. Epub 2008 Mar 27. Eur Arch Otorhinolaryngol. 2008. PMID: 18368417 Free PMC article. Review.
Peripheral facial nerve palsy (FNP) may (secondary FNP) or may not have a detectable cause (Bell's palsy). ...Bell's palsy may be diagnosed after exclusion of all secondary causes, but causes of secondary FNP and Bell's palsy may coexist. Treatment of secondary FNP is base …
Peripheral facial nerve palsy (FNP) may (secondary FNP) or may not have a detectable cause (Bell's palsy). ...Bell's palsy may be dia …
Facial paralysis: Clinical practice guideline of the Spanish Society of Otolaryngology.
Lassaletta L, Morales-Puebla JM, Altuna X, Arbizu Á, Arístegui M, Batuecas Á, Cenjor C, Espinosa-Sánchez JM, García-Iza L, García-Raya P, González-Otero T, Mañós M, Martín C, Moraleda S, Roda JM, Santiago S, Benítez J, Cavallé L, Correia V, Estévez JM, Gómez J, González R, Jiménez J, Lacosta JL, Lavilla MJ, Peñarrocha J, Polo R, García-Purriños F, Ramos F, Tomás M, Uzcanga M, Vallejo LÁ, Gavilán J. Lassaletta L, et al. Acta Otorrinolaringol Esp (Engl Ed). 2020 Mar-Apr;71(2):99-118. doi: 10.1016/j.otorri.2018.12.004. Epub 2019 May 13. Acta Otorrinolaringol Esp (Engl Ed). 2020. PMID: 31097197 English, Spanish.
Bell's palsy is the most common diagnosis associated with facial nerve weakness or paralysis. However, not all patients with facial paresis/paralysis have Bell's palsy. ...The purpose of this guideline is to provide clinicians with guidance on t …
Bell's palsy is the most common diagnosis associated with facial nerve weakness or paralysis. However, not all patients …
Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.
Sundaram H, Signorini M, Liew S, Trindade de Almeida AR, Wu Y, Vieira Braz A, Fagien S, Goodman GJ, Monheit G, Raspaldo H; Global Aesthetics Consensus Group. Sundaram H, et al. Plast Reconstr Surg. 2016 Mar;137(3):518e-529e. doi: 10.1097/01.prs.0000475758.63709.23. Plast Reconstr Surg. 2016. PMID: 26910696 Free PMC article. Review.
This publication on botulinum toxin type A considers advances in facial analysis, injection techniques, and avoidance and management of complications. ...The indication for selection of botulinum toxin as a primary intervention is that excessive muscular contraction is the …
This publication on botulinum toxin type A considers advances in facial analysis, injection techniques, and avoidance and management …
Guillain-Barre syndrome: clinical profile and management.
Sudulagunta SR, Sodalagunta MB, Sepehrar M, Khorram H, Bangalore Raja SK, Kothandapani S, Noroozpour Z, Aheta Sham M, Prasad N, Sunny SP, Mohammed MD, Gangadharappa R, Nidsale Sudarshan R. Sudulagunta SR, et al. Ger Med Sci. 2015 Sep 21;13:Doc16. doi: 10.3205/000220. eCollection 2015. Ger Med Sci. 2015. PMID: 26421004 Free PMC article.
Neurological analysis revealed cranial nerve involvement in 407 (34.90%) patients, facial palsy in 401 (34.39%) and ataxia in 88 (7.54%) patients. Most patients in plasma exchange group belonged to the lower socio-economic status. ...
Neurological analysis revealed cranial nerve involvement in 407 (34.90%) patients, facial palsy in 401 (34.39%) and ataxia in 88 (7.5 …
Botulinum toxin treatment for facial palsy: A systematic review.
Cooper L, Lui M, Nduka C. Cooper L, et al. J Plast Reconstr Aesthet Surg. 2017 Jun;70(6):833-841. doi: 10.1016/j.bjps.2017.01.009. Epub 2017 Feb 16. J Plast Reconstr Aesthet Surg. 2017. PMID: 28389084 Review.
Botulinum toxin is increasingly used in the management of facial palsy; however, the optimum dose, treatment interval, adjunct therapy and performance as compared with alternative treatments have not been well established. ...Botulinum toxin injections represent a m …
Botulinum toxin is increasingly used in the management of facial palsy; however, the optimum dose, treatment interval, adjunct the …
Moebius syndrome: clinical features, diagnosis, management and early intervention.
Picciolini O, Porro M, Cattaneo E, Castelletti S, Masera G, Mosca F, Bedeschi MF. Picciolini O, et al. Ital J Pediatr. 2016 Jun 3;42(1):56. doi: 10.1186/s13052-016-0256-5. Ital J Pediatr. 2016. PMID: 27260152 Free PMC article.
BACKGROUND: Moebius syndrome (MBS) is rare disease characterized by nonprogressive congenital uni- or bi-lateral facial (i. e. VII cranial nerve) and abducens (i. e. VI cranial nerve) palsy. ...Their development was characterized by global delay at one year of age, motor, …
BACKGROUND: Moebius syndrome (MBS) is rare disease characterized by nonprogressive congenital uni- or bi-lateral facial (i. e. VII cr …
511 results